Merck & Co.
213 E Grand Avenue, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA 02141
United States
4224 articles about Merck & Co.
-
Merck & Co., Inc. Rotavirus Vaccine Not Linked to Bowel Problems in Study
2/8/2012
-
Merck & Co., Inc. Reports Postive Phase III Insomnia Results, to File NDA This Year
2/7/2012
-
Merck & Co., Inc. Clot Drug Meets Study Goal But Bleeding a Risk
2/7/2012
-
Merck & Co., Inc. Loses Trade Secrets Battle in Canada
2/6/2012
-
FDA OKs Merck & Co., Inc.'s Janumet XR for Type 2 Diabetes
2/6/2012
-
Depomed, Inc. Announces FDA Approval of Merck & Co., Inc.'s JANUMET(R) XR That Accesses Depomed Patents Licensed to Merck
2/6/2012
-
Merck & Co., Inc. Swings to Profit on Fewer Charges, Sales Growth
2/3/2012
-
Merck & Co., Inc. Announces Full-Year and Fourth-Quarter 2011 Financial Results
2/2/2012
-
Merck & Co., Inc. Consolidates Animal Health Offices; Axes 65 Jobs
2/1/2012
-
Reminder: Merck & Co., Inc. to Hold 2011 Full-Year and Fourth-Quarter Sales and Earnings Conference Call on February 2
1/26/2012
-
Merck & Co., Inc. Gets Positive CHMP Opinion for Remicade in New Indication
1/26/2012
-
Merck & Co., Inc.'s Cholesterol Drug Vytorin to Get New Label
1/25/2012
-
Merck & Co., Inc. to Settle Canada Vioxx Suits for Up to C $37 Million
1/20/2012
-
Merck & Co., Inc. May Consider Acquisitions to Expand Hepatitis C Drug Lineup
1/11/2012
-
Merck & Co., Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference
1/9/2012
-
Idera Pharmaceuticals, Inc. Announces Selection of Toll-like Receptor Agonist Candidates for Evaluation as Vaccine Adjuvants by Merck & Co., Inc.
1/9/2012
-
Merck & Co., Inc.'s Frazier Eyes Partnerships, Acquisitions
1/5/2012
-
Merck & Co., Inc. Invests Up to $17 Million in Mobile Healthcare Solutions Company
1/5/2012
-
Merck & Co., Inc. to Present at Goldman, Sachs & Co. 2012 Healthcare Event
1/4/2012
-
FDA OKs Merck & Co., Inc.'s Isentress for Youngsters With HIV
12/22/2011